Sage Therapeutics, Inc. 4
4 · Sage Therapeutics, Inc. · Filed Feb 10, 2016
Insider Transaction Report
Form 4
Anderson Thomas
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2016-02-08+22,500→ 22,500 totalExercise: $28.63Exp: 2026-02-08→ Common Stock (22,500 underlying)
Footnotes (1)
- [F1]The securities awarded on 2/08/2016 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 5,625 shares of common stock shall vest on the one year anniversary of the Vesting Start Date with 16,875 shares vesting in 36 equal monthly installments thereafter.